Koninklijke Philips NV vs Vanguard High Dividend Yield ETF — how do they compare? Koninklijke Philips NV trades at $24.24 (market cap $23.52B), while Vanguard High Dividend Yield ETF trades at $158.75 (market cap $100.80B). The key difference: Vanguard High Dividend Yield ETF is far larger — about 4.3× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays a 4.17% dividend while Vanguard High Dividend Yield ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Koninklijke Philips NV for 84 Days and Vanguard High Dividend Yield ETF for 139 Days on average.
| PHG | VYM | |
|---|---|---|
Market Cap | $23.52B | $100.80B |
Volume | 1,635,069 | 908,176 |
Sector | Health | — |
52-Week High | $32.91 | $167.03 |
52-Week Low | $23.81 | $137.47 |
Typical Hold Time | 84 Days | 139 Days |
Enterprise Value | $29.87B | — |
Dividend Yield | 4.17% | — |
Signals from Pluang's Aura AI — not financial advice
PHG trades at $24.30, up 0.87% with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with net income turning positive to $895M in 2025 after previous losses, supported by strong cash flow generation. Recent news highlights product innovations including new CT systems and AI healthcare advancements, while institutional ownership shows mixed activity.
The outlook remains cautious with analyst consensus at Hold (63.64%) despite positive earnings momentum. Key risks include cybersecurity threats and competitive pressures in health technology. The stock presents a recovery opportunity but requires monitoring of execution risks and market sentiment shifts.
VYM trades at $158.25, up 0.51% with a bearish technical signal. The ETF shows neutral momentum oscillators but bearish moving averages, with key support at $156 and resistance at $159. Recent news highlights VYM's consistent dividend yield of 2.42% but notes competitive pressure from alternatives like SCHD and IDV, which have outperformed recently. The fund's index methodology has faced criticism for holding stocks like Intel and Walgreens through dividend cuts.
Outlook remains cautious due to technical bearishness and competitive headwinds. While VYM offers broad diversification and low costs, investors face risks from its yield-focused strategy potentially including dividend-cut vulnerable stocks. The fund serves income investors but may underperform more dynamic dividend strategies in current market conditions.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VYM →